Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 17;100(7):411-417.
doi: 10.1136/sextrans-2023-056015.

Prevalence of sexually transmitted infections and associated risk factors among female sex workers in Guinea-Bissau

Jacob Lindman  1 , Mamadu Aliu Djalo  2 , Ansu Biai  3 , Fredrik Månsson  4 , Daniel Golparian  5 , Joakim Esbjörnsson  4 , Marianne Jansson  6 , Patrik Medstrand  6 , Magnus Unemo  5   7 , Hans Norrgren  8 ; Sweden Guinea-Bissau Cohort Research (SWEGUB CORE) group; SWEGUB CORE group
Collaborators, Affiliations

Prevalence of sexually transmitted infections and associated risk factors among female sex workers in Guinea-Bissau

Jacob Lindman et al. Sex Transm Infect. .

Abstract

Objective: To estimate the prevalence of the curable sexually transmitted infections (STIs) Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and Treponema pallidum, to identify associated risk factors and to assess ciprofloxacin resistance in N. gonorrhoeae-positive specimens among female sex workers (FSWs) in Guinea-Bissau.

Methods: For this cross-sectional study, FSWs were recruited from October 2014 to May 2019. A questionnaire on STI risk factors was completed by the study participants, and the women were asked to provide a vaginal swab for nucleic acid amplification tests for C. trachomatis, N. gonorrhoeae, M. genitalium, T. vaginalis (Aptima, Hologica), as well as a blood sample for T. pallidum serological testing and discriminatory HIV-testing. The prevalence of STIs was determined, and multivariate logistic regression was used to identify STI risk factors.

Results: The study included 467 women. The prevalence of current infection with any curable STI was 46.7%, and the most common pathogen was T. vaginalis (26.3%), followed by M. genitalium (21.9%), C. trachomatis (11.8%), N. gonorrhoeae (10.1%) and T. pallidum (2.8%). The proportion of asymptomatic infections among the diagnosed STIs was 61.8%, 61.5%, 55.3%, 55.3% and 52.2% for C. trachomatis, T. pallidum, N. gonorrhoeae, T. vaginalis and M. genitalium, respectively. The prevalence of the gyrA S91F mutation conferring ciprofloxacin resistance in N. gonorrhoeae-positive specimens was 84.0%. Significant risk factors for having a curable STI were age and HIV-1 infection, while use of female condoms was a protective factor.

Conclusion: This study demonstrated that the prevalence of curable STIs was high among FSWs in Guinea-Bissau during the study period, indicating an unmet need for STI services. Moreover, the results indicated that symptomatic treatment might be insufficient, highlighting a need for periodic aetiological testing to facilitate detection of asymptomatic as well as symptomatic STIs to stop ongoing transmission.

Keywords: AFRICA; Chalmydia Trachomatis; Mycoplasma genitalium; NEISSERIA GONORRHOEAE; Sex Work.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. Flow chart indicating the number of study participants included in the data analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. WHO . Geneva: World Health Organization; 2018. Report on global sexually transmitted infection surveillance, 2018.
    1. Manhart LE. Mycoplasma genitalium: an emergent sexually transmitted disease? Infect Dis Clin North Am. 2013;27:779–92. doi: 10.1016/j.idc.2013.08.003. - DOI - PubMed
    1. Tacconelli E, Magrini N, Kahlmeter G, et al. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017
    1. Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27:587–613. doi: 10.1128/CMR.00010-14. - DOI - PMC - PubMed
    1. Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect. 2000;76:80–7. doi: 10.1136/sti.76.2.80. - DOI - PMC - PubMed

Publication types

MeSH terms